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Introduction
a1 - antitrypsin (AAT) is a member of the serine protease
inhibitor supergene family. The AAT deficiency is most
often associated with the Z mutation and can contribute
to the development of chronic obstructive pulmonary
disease and liver pathology. The presence of arthritis with
AAT deficiency has also been described.
Objectives
To describe the cases of arthritis in children with AAT
deficiency.
Methods
The description of four cases. The AAT deficiency was
found in three brothers (two with juvenile idiopathic
arthritis (JIA), one reactive arthritis) and in a girl with
JIA. While looking for possible cause(s) for hypertransa-
minasemia, the girl’s and one of the brother’s serum
level of AAT was found to be below the normal range;
the analysis of the other two brothers was ordered spe-
cially. In all cases the gene diagnostics was performed.
Results
Arthritis in these children was diagnosed at the age of 8-
15 years. All the three JIA patients have polyarticular
course (two extended oligoarthritis, one subtype other
arthritis), negative antinuclear antibodies, one has positive
rheumatoid factor. No one had previous history of bron-
chitis. Two brothers (one with JIA) are overweight with
body mass indexes as 26,3 kg/m2 and 33,8 kg/m2. All the
JIA patients have recieved disease modifying antirheumatic
drugs (DMARDs): three plaquenil (2 in combination with
trexane), one imuran. The serum levels of transaminases -
ASAT and/or ALAT - were 1,5-2 times higher than the
normal upper limit in two JIA patients. The other two
patients had normal values. The girl with JIA had higher
ASAT level just once before starting the DMARD, one
brother presented with high values of ASAT and ALAT
during the treatment. Three patients had AAT deficiency
in repeated analyses (0.68-0.97 g/l). All the three brothers
have the same mutation (in the protein E366K) in one
gene copy of the AAT gene - they are carriers of the Z
mutation (genotype Pi*MZ). The girl has S mutation (in
the protein E288V) in one gene copy of the AAT gene -
she is heterozygous for S mutation (genotype Pi*MS).
Conclusion
Deficiency of AAT can be found in patients with arthritis.
When performing blood tests seeking for cause(s) of
hypertransaminasemia, the level of AAT should be
checked; when the deficiency is present in repeated
analyses, gene diagnostics should be done to specify the
risk of organ damage and avoid the risk factors.
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